International Health Care Procurement Whistleblowers Are Receiving Large Rewards for Exposing Government Health Care Procurement Bribe Schemes & other Government Procurement Corruption by International Government Health Care Procurement Bribe Whistleblower Lawyer, International Health Care Procurement Contract Bribe Lawyer, & International Pharmaceutical Procurement Illegal Kickback Whistleblower Attorney Jason Coomer

International Procurement Whistleblowers Are Receiving Large Rewards for Exposing Government Health Care Procurement Bribe Schemes and other Government Procurement Corruption by International Government Health Care Procurement Bribe Whistleblower Lawyer, International Pharmaceutical Procurement Contract Bribe Lawyer, and International Health Care Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

Worldwide government purchasing or government procurement is estimated to be over $10 Trillion each year.  Of this large amount of government purchasing, it is estimated that as much as 20% may be through illegal bribes, kickbacks, and other illicit payments.  Government procurement spending includes military spending; public works projects; public health care (pharmaceuticals, medical equipment, & hospitals); ports, transportation, & roads; mining and oil extraction; power grid and stations; education; law enforcement; and sanitation services.  Because of the vast amount of money spent by governments on government procurement, there are many different types of government procurement illegal bribery schemes, illegal kickback schemes, and other illicit payment schemes that have been created to steal money from the public at the expense of a country's citizens.

Chinese Health-Care System Rife With Corruption Risks - Corruption Currents - WSJ

"Western companies seeking to find their way into China’s largely state-run health care system face heightened risks now that the Chinese government is planning to investigate drug-procurement and medical-device tendering. The tendering and procurement process is opaque and fragmented, giving companies more headaches when they try to enter the market, experts said."

"It becomes a bigger problem given news that China’s government, according to recent reports, is going to start inspecting hospitals’ invoices in a bid to curb commercial bribery and money laundering during the procurement process."

"The U.S. Justice Department has been in the middle of sweeping probes into both the pharmaceutical and medical-device industries. For example, orthopedic manufacturer Biomet Inc. agreed in March to pay the U.S. $22 million to settle FCPA charges that the company paid more than $1.5 million in direct and indirect payments to employees of state-owned health care providers in Argentina, Brazil and China to secure lucrative business with hospitals. The company didn’t enter a guilty plea, but accepted responsibility for the allegations laid out in court documents."

 International Health Care Procurement Whistleblowers Are Needed to Expose Government Health Care Procurement Bribe Schemes and other Government Procurement Corruption by International Government Medicine Procurement Bribe Whistleblower Lawyer, International Drug Procurement Contract Bribe Lawyer, and International Health Care Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications.  In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to 7% to around $880 billion.  This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland and the Ukraine.  These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

Eight pharmerging countries are amongst the top 20 world pharmaceutical markets, and China is one of the “top three” or will be in the near future.  A few high-profile pharmaceutical companies have been successful in gaining a foothold in these pharmering countries.  These footholds include Abbott’s acquisition of Piramal Healthcare in India — a deal that could potentially make the US giant the top player in this country.  Bayer's and Novartis' investments in China including Novartis'  commitment to invest $1 billion USD in R&D in China and its $125 million USD investment to buy 85 percent stake in a privately held vaccine company.  Pfizer has made inroads into the Russian health care system with a discount-card system in Russia  Sanofi Aventis has purchased Medley, Brazil’s third-largest pharmaceutical company.  GSK and Lilly have also announced anticipated doubling their revenue in emerging markets by 2015.

International Health Care Whistleblowers Are Exposing Government Health Care Procurement Bribe Schemes and other Government Procurement Corruption by International Government Health Care Procurement Bribe Whistleblower Lawyer, International Pharmaceutical Procurement Contract Bribe Lawyer, and International Health Care Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

International Whistleblowers along the pharmaceutical supply chain and other health care professionals are being offered large potential rewards to blow the whistle on adulterated pharmaceutical ingredients, adulterated medicine, adulterated drugs, contaminated medical supplies, and defective medical devices.  These whistleblower rewards can come from SEC Whistleblower Reward Lawsuits and traditional Qui Tam False Claims Act Whistleblower Reward Lawsuits.  For more information on these potential whistleblower rewards, feel free to go to the following web pages: Government Contractor Procurement Fraud Lawsuits and International Government Procurement Bribe Whistleblower Rewards, International Procurement Bribe Whistleblower Lawsuits.